These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 28247924)

  • 1. Calcium hydroxylapatite: A review on safety and complications.
    Kadouch JA
    J Cosmet Dermatol; 2017 Jun; 16(2):152-161. PubMed ID: 28247924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aesthetic applications of calcium hydroxylapatite volumizing filler: an evidence-based review and discussion of current concepts: (part 1 of 2).
    Emer J; Sundaram H
    J Drugs Dermatol; 2013 Dec; 12(12):1345-54. PubMed ID: 24301235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium hydroxylapatite filler: an overview of safety and tolerability.
    Pavicic T
    J Drugs Dermatol; 2013 Sep; 12(9):996-1002. PubMed ID: 24002146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multicenter, 47-month study of safety and efficacy of calcium hydroxylapatite for soft tissue augmentation of nasolabial folds and other areas of the face.
    Sadick NS; Katz BE; Roy D
    Dermatol Surg; 2007 Dec; 33 Suppl 2():S122-6; discussion S126-7. PubMed ID: 18086049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium hydroxylapatite (Radiesse) for treatment of nasolabial folds: long-term safety and efficacy results.
    Bass LS; Smith S; Busso M; McClaren M
    Aesthet Surg J; 2010 Mar; 30(2):235-8. PubMed ID: 20442101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complications from Nasolabial Fold Injection of Calcium Hydroxylapatite for Facial Soft-Tissue Augmentation: A Systematic Review and Meta-Analysis.
    Shi XH; Zhou X; Zhang YM; Lei ZY; Liu T; Fan DL
    Aesthet Surg J; 2016 Jun; 36(6):712-7. PubMed ID: 27178901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiographic and computed tomographic studies of calcium hydroxylapatite for treatment of HIV-associated facial lipoatrophy and correction of nasolabial folds.
    Carruthers A; Liebeskind M; Carruthers J; Forster BB
    Dermatol Surg; 2008 Jun; 34 Suppl 1():S78-84. PubMed ID: 18547186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 52-month summary of results using calcium hydroxylapatite for facial soft tissue augmentation.
    Tzikas TL
    Dermatol Surg; 2008 Jun; 34 Suppl 1():S9-15. PubMed ID: 18547188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Open-Label, Post-Marketing Study to Evaluate the Performance and Safety of Calcium Hydroxylapatite With Integral Lidocaine to Correct Facial Volume Loss.
    Muti GF
    J Drugs Dermatol; 2019 Jan; 18(1):86-91. PubMed ID: 30681803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Managing intravascular complications following treatment with calcium hydroxylapatite: An expert consensus.
    van Loghem J; Funt D; Pavicic T; Goldie K; Yutskovskaya Y; Fabi S; Siebenga P; Thuis J; Hkeik J; Kadouch J; Prager W; Azib N; Casabona G; Dayan S; Bay Aguilera S; Snozzi P; Saeed P
    J Cosmet Dermatol; 2020 Nov; 19(11):2845-2858. PubMed ID: 32185876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of calcium hydroxylapatite in the upper third of the face: Retrospective analysis of techniques, dilutions and adverse events.
    Van Loghem JAJ
    J Cosmet Dermatol; 2018 Dec; 17(6):1025-1030. PubMed ID: 30362225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Prospective, Multicenter, Evaluator-Blinded, Randomized Study of Diluted Calcium Hydroxylapatite to Treat Decollete Wrinkles.
    Pavicic T; Kerscher M; Kuhne U; Heide I; Dersch H; Odena G; Graul V
    J Drugs Dermatol; 2024 Jul; 23(7):551-556. PubMed ID: 38954627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and effectiveness of injection of calcium hydroxylapatite via blunt cannula compared to injection by needle for correction of nasolabial folds.
    Beer KR
    J Cosmet Dermatol; 2014 Dec; 13(4):288-96. PubMed ID: 25399621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CALCIUM HYDROXYLAPATITE MICROSPHERES - BIOCOMPATIBILITY AND CLINICAL EFFECTS.
    Wollina U; Wiegand C; Hipler UC
    Georgian Med News; 2018 May; (278):62-68. PubMed ID: 29905547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combining Microfocused Ultrasound With Botulinum Toxin and Temporary and Semi-Permanent Dermal Fillers: Safety and Current Use.
    Fabi SG; Goldman MP; Mills DC; Werschler WP; Green JB; Kaufman J; Weiss RA; Hornfeldt CS
    Dermatol Surg; 2016 May; 42 Suppl 2():S168-76. PubMed ID: 27128245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dilutional rheology of Radiesse: Implications for regeneration and vascular safety.
    McCarthy AD; Soares DJ; Chandawarkar A; El-Banna R; Hagedorn N
    J Cosmet Dermatol; 2024 Jun; 23(6):1973-1984. PubMed ID: 38357772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A systematic review of Radiesse® (calcium hydroxylapatite): evidence and recommendations for the body.
    Galadari H; Guida S
    Int J Dermatol; 2024 Jul; 63(7):881-889. PubMed ID: 38390986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Structured Approach for Treating Calcium Hydroxylapatite Focal Accumulations.
    McCarthy AD; van Loghem J; Martinez KA; Aguilera SB; Funt D
    Aesthet Surg J; 2024 Jul; 44(8):869-879. PubMed ID: 38366791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium hydroxylapatite (Radiesse): safety, techniques and pain reduction.
    Busso M
    J Drugs Dermatol; 2009 Oct; 8(10 Suppl):s21-3. PubMed ID: 19891118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Six-month safety results of calcium hydroxylapatite for treatment of nasolabial folds in Fitzpatrick skin types IV to VI.
    Marmur ES; Taylor SC; Grimes PE; Boyd CM; Porter JP; Yoo JY
    Dermatol Surg; 2009 Oct; 35 Suppl 2():1641-5. PubMed ID: 19708876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.